类风湿关节炎合并肺间质病变的研究进展
Research Progress of Rheumatoid Arthritis Combined with Lung Interstitial Disease
DOI: 10.12677/ACM.2023.1381714, PDF,   
作者: 王英英, 崔轶霞:延安大学附属医院风湿免疫科,陕西 延安
关键词: 类风湿关节炎肺间质病变研究Rheumatoid Arthritis Lung Interstitial Disease Research
摘要: 肺损伤是类风湿关节炎(RA)最常见的关节外表现之一,而肺间质病变(ILD)是类风湿关节炎肺损伤的最常见甚至首发症状,其病因及发病机制尚不明确,本文阐述了目前国内外对类风湿关节炎合并肺间质病变(RA-ILD)的流行病学、病因及发病机制、病理改变、临床表现、辅助检查、诊断及治疗等多方面的研究状况,旨在为RA-ILD病变提供早期诊断及早期治疗的依据,提高患者生存质量,改善患者预后。
Abstract: Lung injury is one of the most common extra-articular manifestations of rheumatoid arthritis (RA), while lung interstitial disease (ILD) is the most common and even the first symptom of RA lung in-jury. The etiology and pathogenesis of ILD are still unclear. This article reviewed the epidemiology, etiology, pathogenesis, pathological changes, clinical manifestations, auxiliary examination, diagno-sis and treatment of rheumatoid arthritis complicated with lung interstitial disease (RA-ILD), aim-ing to provide the basis for early diagnosis and treatment of RA-ILD, improve the quality of life of patients and improve the prognosis of patients.
文章引用:王英英, 崔轶霞. 类风湿关节炎合并肺间质病变的研究进展[J]. 临床医学进展, 2023, 13(8): 12236-12241. https://doi.org/10.12677/ACM.2023.1381714

参考文献

[1] Fazeli, M.S., Khaychuk, V., Wittstock, K., et al. (2021) Rheumatoid Arthritis-Associated Interstitial Lung Disease: Epi-demiology, Risk/Prognostic Factors, and Treatment Landscape. Clinical and Experimental Rheumatology, 39, 1108-1118. [Google Scholar] [CrossRef] [PubMed]
[2] Ellman, P. and Ball, R.E. (1948) “Rheumatoid Disease” with Joint and Pulmonary Manifestations. British Medical Journal, 2, 816-820. [Google Scholar] [CrossRef] [PubMed]
[3] Dai, Y., Wang, W., Yu, Y. and Hu, S. (2021) Rheumatoid Arthri-tis-Associated Interstitial Lung Disease: An Overview of Epidemiology, Pathogenesis and Management. Clinical Rheu-matology, 40, 1211-1220. [Google Scholar] [CrossRef] [PubMed]
[4] Li, L., Liu, R., Zhang, Y., et al. (2020) A Retrospective Study on the Predictive Implications of Clinical Characteristics and Therapeutic Management in Patients with Rheumatoid Arthri-tis-Associated Interstitial Lung Disease. Clinical Rheumatology, 39, 1457-1470. [Google Scholar] [CrossRef] [PubMed]
[5] Hyldgaard, C., Hilberg, O., Pedersen, A.B., et al. (2017) A Pop-ulation-Based Cohort Study of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Comorbidity and Mortality. Annals of the Rheumatic Diseases, 76, 1700-1706. [Google Scholar] [CrossRef] [PubMed]
[6] Yunt, Z.X. and Solomon, J.J. (2015) Lung Disease in Rheumatoid Arthritis. Rheumatic Disease Clinics, 41, 225-236.
[7] Demedts, M. and Costabel, U. (2002) ATS/ERS International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. European Respiratory Journal, 19, 794-796. [Google Scholar] [CrossRef] [PubMed]
[8] Chun, M.P., Park, M.S., Oh, I.J., et al. (2020) Safety and Ef-ficacy of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis: A Nationwide Post-Marketing Surveillance Study in Korean Patients. Advances in Therapy, 37, 2303-2316. [Google Scholar] [CrossRef] [PubMed]
[9] 焦桐. 类风湿关节炎相关间质性肺病中医证候特征及肠道、舌苔菌群分析[D]: [硕士学位论文]. 天津: 天津中医药大学, 2022.
[10] Raghu, G., Remy-Jardin, M., Myers, J.L., et al. (2018) Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine, 198, e44-e68. [Google Scholar] [CrossRef
[11] Travis, W.D., Costabel, U., Hansell, D.M., et al. (2013) An Of-ficial American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias. American Journal of Respiratory and Critical Care Medicine, 188, 733-748. [Google Scholar] [CrossRef
[12] Bendstrup, E., Møller, J., Kronborg-White, S., et al. (2019) In-terstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians. Journal of Clinical Medicine, 8, Arti-cle No. 2038. [Google Scholar] [CrossRef] [PubMed]
[13] Doyle, T.J., Hunninghake, G.M. and Rosas, I.O. (2012) Subclinical Interstitial Lung Disease: Why You Should Care. American Journal of Respiratory and Critical Care Medi-cine, 185, 1147-1153. [Google Scholar] [CrossRef
[14] Afeltra, A., Zennaro, D., Garzia, P., et al. (2006) Prevalence of Interstitial Lung Involvement in Patients with Connective Tissue Diseases Assessed with High-Resolution Computed Tomography. Scandinavian Journal of Rheumatology, 35, 388-394. [Google Scholar] [CrossRef] [PubMed]
[15] Lee, H.-K., Kim, D.S., Yoo, B., et al. (2005) Histopathologic Pattern and Clinical Features of Rheumatoid Arthritis-Associated Interstitial Lung Disease. Chest, 127, 2019-2027. [Google Scholar] [CrossRef] [PubMed]
[16] Brown, K.K. (2007) Rheumatoid Lung Disease. Proceedings of the American Thoracic Society, 4, 443-448. [Google Scholar] [CrossRef
[17] 申明. 类风湿关节炎相关肺间质病变的危险因素、临床和影像学特点[J]. 影像研究与医学应用, 2019, 3(12): 87-88.
[18] 韩雪兰. 类风湿关节炎合并间质性肺疾病的临床、影像学和肺功能分析[D]: [硕士学位论文]. 长春: 吉林大学, 2016.
[19] Wang, T., Zheng, X.-J., Liang, B.-M. and Liang, Z.-A. (2015) Clinical Features of Rheumatoid Arthritis-Associated Interstitial Lung Disease. Scientific Reports, 5, Article No. 14897. [Google Scholar] [CrossRef] [PubMed]
[20] Ascherman, D.P. (2010) Interstitial Lung Disease in Rheumatoid Arthritis. Current Rheumatology Reports, 12, 363-369. [Google Scholar] [CrossRef] [PubMed]
[21] Salaffi, F., Manganelli, P., Carotti, M. and Baldelli, S. (2000) The Differing Patterns of Subclinical Pulmonary Involvement in Connective Tissue Diseases as Shown by Application of Factor Analysis. Clinical Rheumatology, 19, 35-41.
[22] Kaarteenaho, R. (2013) The Current Position of Surgical Lung Biopsy in the Diagnosis of Idiopathic Pulmonary Fibrosis. Respiratory Research, 14, Article No. 43. [Google Scholar] [CrossRef] [PubMed]
[23] Raghu, G., Mageto, Y.N., Lockhart, D., et al. (1999) The Accuracy of the Clinical Diagnosis of New-Onset Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Disease: A Prospec-tive Study. Chest, 116, 1168-1174. [Google Scholar] [CrossRef] [PubMed]
[24] Arnett, F.C., Edworthy, S.M., Bloch, D.A., et al. (1988) The Amer-ican Rheumatism Association 1987 Revised Criteria for the Classification of Rheumatoid Arthritis. Arthritis & Rheuma-tism, 31, 315-324. [Google Scholar] [CrossRef] [PubMed]
[25] Aletaha, D., Neogi, T., Silman, A.J., et al. (2010) 2010 Rheumatoid Arthritis Classification Criteria: An American College of Rheumatology/European League against Rheumanism Collabo-rative Initiative. Annals of the Rheumatic Diseases, 69, 1580-1588. [Google Scholar] [CrossRef] [PubMed]
[26] Huppmann, P., Sczepanski, B., Boensch, M., et al. (2012) Effects of Inpatient Pulmonary Rehabilitation in Patients with Interstitial Lung Disease. European Respiratory Journal, 42, 444-453. [Google Scholar] [CrossRef] [PubMed]
[27] 黄嘉明. 类风湿关节炎相关间质性肺疾病的临床特征和危险因素分析[D]: [硕士学位论文]. 广州: 广州医科大学, 2021.
[28] Semenzato, G., Adami, F., Maschio, N. and Agos-tini, C. (2000) Immune Mechanisms in Interstitial Lung Disease. Allergy, 55, 1103-1120. [Google Scholar] [CrossRef] [PubMed]
[29] 左婷, 李向培. 结缔组织病肺间质纤维化治疗进展[J]. 安徽医药, 2015(5): 821-825.
[30] Saravanan, V. and Kelly, C.A. (2006) Drug-Related Pulmonary Problems in Patients with Rheumatoid Arthritis. Rheumatology, 45, 787-790. [Google Scholar] [CrossRef] [PubMed]
[31] 周雯怡, 杨雅竹, 谢敏, 田雨, 苏励. 类风湿关节炎肺间质病变特点及中西医治疗进展[J]. 医学研究杂志, 2022, 51(10): 20-23.
[32] Hadjinicolaou, A.V., Nisar, M.K., Bhagat, S., et al. (2011) Non-Infectious Pulmonary Complications of Newer Biological Agents for Rheumatic Diseases—A Systematic Literature Review. Rheumatology, 50, 2297-2305. [Google Scholar] [CrossRef] [PubMed]
[33] Huang, Y., Lin, W., Chen, Z., et al. (2019) Effect of Tumor Ne-crosis Factor Inhibitors on Interstitial Lung Disease in Rheumatoid Arthritis: Angel or Demon. Drug Design, Develop-ment and Therapy, 13, 2111-2125. [Google Scholar] [CrossRef
[34] MacIsaac, J., Siddiqui, R., Jamula, E., et al. (2018) Systematic Re-view of Rituximab for Autoimmune Diseases: A Potential Alternative to Intravenous Immune Globulin. Transfusion, 58, 2729-2735. [Google Scholar] [CrossRef] [PubMed]
[35] 卜祥伟, 张红红, 张建萍, 等. 类风湿关节炎的中医药研究进展[J]. 环球中医药, 2019, 12(2): 297-303.
[36] Demedts, M., Behr, J., Buhl, R., et al. (2005) High-Dose Acetylcys-teine in Idiopathic Pulmonary Fibrosis. New England Journal of Medicine, 353, 2229-2242. [Google Scholar] [CrossRef
[37] Bongartz, T., Nannini, C., Medina-Velasquez, Y.F., et al. (2010) In-cidence and Mortality of Interstitial Lung Disease in Rheumatoid Arthritis: A Population-Based Study. Arthritis & Rheumatology, 62, 1583-1591. [Google Scholar] [CrossRef] [PubMed]